InvestorsHub Logo
Followers 253
Posts 17906
Boards Moderated 0
Alias Born 01/19/2006

Re: JRoon71 post# 420989

Tuesday, 01/30/2024 9:34:54 AM

Tuesday, January 30, 2024 9:34:54 AM

Post# of 423976
Look at a 5-year chart. AMRN was in the $18-20 range. Then consider all the approvals since, not extant when Dr. Bhatt released preliminary results at AHA in Chicago. I agree with others who are looking for a $18-20 buyout. A petition to the FDA Commissioner, a cardiologist, just might force generics to make a label change: “This product is not approved for use in treating cardiovascular diseases.” Stay tuned.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News